MSB mesoblast limited

1.85%

$1.65

Ann: Ryoncil Pricing Set and Available This Quarter, page-221

First 221 Last

Share
Profile

Follow
Pledge

8,722 Posts.

1455

27/02/25

15:46

Post #: 78058507
Share

Originally posted by Bazsa: ↑

Great post,

"When are those wonderful Australian biotech and healthcare analysts going to do their job and make their clients money."

Could I suggest that they are doing it now and they have been doing it for some time.

Many times these guys remain silent or perhaps even put out news or tall stories to create a very positive buying environment.

Look what happened when Dr George was buying. Did we hear any thing about the probability of ASX 200 inclusion. No, silence was the go. We know from the turn over it was not just the Dr. buying. Our not so much good friend over on the other sight hit me for six , even came up with his calculations that showed we had next to no chance. How funny, a couple of weeks later in came the reports of "very strong probability of inclusion in the March rebalance " this at a time when GG had stopped buying and the probability of inclusion fell away big time. Interestingly ET's annalise was at no stage any were near hitting the inclusion criteria. ET's backflip was breathtaking.

ET's knowledge is undeniable, he shares a lot of very useful information nevertheless he is obviously connected to instos, he is there tool to spread misleading information and negativity to our very capable board. His defence of M & G is in my opinion totally invalid. They were in significant part responsible for what was very nearly a failed CR at 30 cents and the potential bankruptcy of our company. For those that think I am jumping at shadows I would suggest taking a look at the last M&G notice .

It is with very good reason that our last two CRs have been designed in such a way to prevent the likes of M&G buying in.
These guys are multiples worse than any shorter.

Expand

What a load of utter BS.

Poor Silviu. Awwwww, there's nothing he could do, M&G MADE him run the business into the ground and they made him and GG buy all those shares at 30c..............??!!

You are utterly broken.

You're the John Travolta of the ScienceTology group.

MSB Price at posting: $2.50 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

First 221 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.65		Change 0.030(1.85%)		Mkt cap ! $2.108B

Open	High	Low	Value	Volume
$1.64	$1.67	$1.63	$4.884M	2.962M

Buyers (Bids)

No.	Vol.	Price($)
3	10583	$1.65

Sellers (Offers)

Price($)	Vol.	No.
$1.66	16415	4

View Market Depth

No.	Vol.	Price($)
3	10583	1.650
2	23000	1.645
4	27999	1.640
1	876	1.635
4	18446	1.630

Price($)	Vol.	No.
1.660	10415	2
1.665	30000	2
1.670	16598	2
1.675	4000	1
1.680	17509	4

Last trade - 16.12pm 27/06/2025 (20 minute delay)

MSB (ASX) Chart

Ann: Ryoncil Pricing Set and Available This Quarter, page-221

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Ryoncil Pricing Set and Available This Quarter, page-221

Top Stories

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News